TNFRSF17 and Miyoshi myopathy: In addition, an impressive 72.2% of patients achieved a CR, indicating a substantial reduction or elimination of MM cells Among the four patients previously treated with murine BCMA CAR therapy, three achieved stringent complete response, and one achieved a very good partial response.